Pethema registry
Webon behalf of PETHEMA Group The hypomethylating agents, decitabine (DEC) and azacitidine (AZA), allowed more elderly acute myeloid leukemia (AML) patients to be treated. However, there are little... Web17. feb 2024 · The PETHEMA AML registry (NCT02607059) includes patients diagnosed with AML, regardless of the treatment administered. Patient and disease characteristics, …
Pethema registry
Did you know?
Web21. máj 2024 · Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review Marta Sobas 1, Maria Carme Talarn-Forcadell 2, David Martínez-Cuadrón 3,4, Lourdes Escoda 2, María J. García-Pérez 5, Jose Mariz 6, María J. Mela-Osorio 7, Isolda Fernández 7, Juan M. Alonso-Domínguez 8, Javier Cornago … Web5. nov 2024 · Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry. Pilar Martínez, MD, *, 1 Tomás Palanques Pastor, *, 2 Jose Luiz …
WebNumerology (Expression Number) 22. Heart's Desire number. 11. Personality Number. 11. Talent analysis of Peema by expression number 22. “You are the master builder. You … Web1. máj 2024 · For this, a total of 1724 elderly AML patients and treated with intensive chemotherapy regimens were identified in the PETHEMA registry. Median age was 67.2 years (range, 60–84,9) and median overall survival [OS] 9 …
Web21. máj 2024 · The characteristics of new 11 variant APL cases registered by the PETHEMA group are in line with prior reports (male predominance, PLZF-RAR α as more frequent … Web9. dec 2013 · Epidemiologic Registry PETHEMA LMA 2013 The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. ClinicalTrials.gov Identifier: NCT02006004 Recruitment Status : Completed
Web22. feb 2024 · The PETHEMA AML registry (NCT02607059) includes patients diagnosed with AML, regardless of the treatment administered. Patient and disease characteristics, in addition to treatment approaches and outcomes, were collected retrospectively, including demographics (age and gender), cytomorphological subtype of AML, cytogenetics, details …
Web29. mar 2024 · para el Tratamiento de las Hemopatías Malignas (PETHEMA) epidemiologic registry. 2. Materials and Methods 2.1. Study Design and Patients The PETHEMA AML registry (NCT02607059) includes patients diagnosed with AML, regardless of previous treatments. We retrospectively collected the main patient charac-teristics, treatment … sustainable urban and rural developmentWeb9. máj 2024 · lignas (PETHEMA) epidemiologic registry. We also aim to evaluate the potential predic‐ tors associated with response and OS with each drug. 2. Patients and Methods 2.1. PETHEMA Registry The PETHEMA registry (NCT02607059) is an epidemiological registry of adult pa‐ tients with newly diagnosed AML. size of jupiter\u0027s magnetosphereWeb9. máj 2024 · This study aims to analyze the treatment strategies and clinical outcomes of very old APL patients reported to the international PETHEMA registry. Between 1997 and 2024, among 2501 APL cases registered 120 were ≥75 years old. Treatment approaches were: AIDA regimen, 79 patients; ATRA alone, 23; 16, supportive care (SC) and 2, other … size of kallax cubeWebThe PETHEMA registry (NCT02607059) is an epidemiological registry of adult patients with newly diagnosed AML. It retrospectively collects the characteristics of AML and the usual practices of the Spanish centers, irrespective of the age of the patients and the treatment received. 2.2. Eligibility sustainable urban forest coalitionWeb6. dec 2006 · Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005): Remission Induction With ATRA + Idarubicin. Risk-adapted … sustainable upland agricultureWebPekema Name Meaning. Historically, surnames evolved as a way to sort people into groups - by occupation, place of origin, clan affiliation, patronage, parentage, adoption, and even … sustainable underwear women ukWeb23. dec 2024 · Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience. Labrador J, Saiz-Rodríguez M, de Miguel D, de Laiglesia A , ... sustainable urban drainage funding